Page last updated: 2024-08-23
amitraz and paclitaxel
amitraz has been researched along with paclitaxel in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adelaïde, J; Bertucci, F; Carbuccia, N; Chaffanet, M; Dalenc, F; Garnier, S; Goncalves, A; Guille, A; Isambert, N; Levy, C; Mamessier, E; Pakradouni, J; Robert, M; Sabatier, R; Sfumato, P; Vicier, C | 1 |
Trials
1 trial(s) available for amitraz and paclitaxel
| Article | Year |
|---|---|
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
Topics: Angiogenesis Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Circulating Tumor DNA; Female; Humans; Mutation; Paclitaxel; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Toluidines | 2022 |